v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Income:    
Revenue
Expenses:    
Research and development 20,057 20,918
General and administrative 184,896 221,303
Interest 93,370 96,333
Total expenses 298,323 338,554
Net loss $ (298,323) $ (338,554)
Loss per share:    
Basic and diluted (in dollars per share) $ (0.004) $ (0.005)
Weighted average shares outstanding, basic and diluted (in shares) 68,622,677 67,278,621

Source